Mirtazapine Tablet, Film Coated
Product Images NDC 68071-2784

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 68071-2784). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2784 9)

Pdp (68071 2784 9)
Label for Mirtazapine 15 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The label indicates a package count of 90 tablets. It includes details such as the capsule shape (biconvex yellow tablet with specific debossed markings) and relevant identification codes including NDC 68071-2784-9. Manufacturer information lists Aurobindo Pharma Limited, India. The label cautions to keep the product out of reach of children and to store at controlled temperatures.*
FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical Structure (Mirtazapine Str)
Chemical structure of Mirtazapine, depicted as a molecular diagram showing its ring structure and methyl group. This structure represents the active ingredient of the drug Mirtazapine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.